Percutaneous fluoroscopically guided jejunostomy placement.

PURPOSE: To describe our experience with fluoroscopically guided direct jejunostomy placement in patients with enterocutaneous fistula, or neoplastic or postsurgical changes of the stomach or duodenum that preclude traditional gastrostomy placement. MATERIALS: Nineteen patients underwent percutaneous direct jejunostomy tube placement with fluoroscopic guidance from August 2004 through March 2006. There were 15 men and four women whose ages ranged from 28 to 82 years (mean, 54 years). Seven patients had surgical changes to the stomach that precluded traditional gastrostomy access, one patient had a duodenal tumor, two had unresectable gastric tumors, and nine had small bowel pathology that required distal access. RESULTS: Jejunal access was initially successful in 18 of 19 (95%) procedures. Follow-up ranged from 10 days to 509 days. Two catheters were removed as they were no longer needed. Seven patients' initial tubes were still functioning at the end of their follow-up. One tube was removed secondary to pain and irritation at the insertion site. Three tubes were occluded. One patients' tube was inadvertently pulled out. In two patients, feeding was not tolerated secondary to fistula distal to the jejunostomy. Two patients died with their initial tubes. Primary patency was 285 days (95% CI 162-407). One death occurred 10 days postprocedure for a 30-day mortality of 1 of 19 (5%). CONCLUSIONS: Percutaneous direct jejunostomy placement is a relatively safe and effective means of gaining enteral access in patients who have enterocutaneous fistula or who have either postsurgical or neoplastic changes of the stomach that preclude traditional gastrostomy placement.

Parapneumonic empyema diagnosed by chest radiograph and computed tomography.

Pleural effusion is commonly seen associated with pneumonia. When this progresses to empyema, directed therapy is frequently required. Chest radiographic and computed tomography findings can help distinguish empyema from a transudative pleural effusion.

Evaluation of the Amplatzer vascular plug for proximal splenic artery embolization.

PURPOSE: Proximal splenic artery embolization is performed for splenic salvage in the setting of trauma or before splenectomy in patients with splenomegaly. Typically, this has been done with the use of metallic coils, but precise placement of the first deposited coil may be limited. The Amplatzer vascular plug (AVP) may be used to accomplish precise proximal splenic artery embolization. MATERIALS AND METHODS: Fourteen patients had proximal splenic artery embolization performed with the AVP. Thirteen were performed to allow splenic salvage after blunt trauma and one was performed before splenectomy for massive splenomegaly. Devices ranging in diameter from 8 to 12 mm were placed through 5-F or 6-F guiding catheters. Desired AVP location was distal to the dorsal pancreatic artery and proximal to the most peripheral pancreatica magna branch. Test injections of contrast agent were performed after approximately 5 minutes and then at 3-5-minute intervals until occlusion was seen. If this was not noted by 15 minutes, an adjunctive closure method was chosen. Computed tomography (CT) follow-up was performed in all patients. RESULTS: Device placement in the desired location was successful in all cases, with device repositioning required in two. Occlusion took an average of approximately 10 minutes. Additional coils placed in three patients could all be packed into a tight configuration. A second AVP was placed in one patient. There were no complications of the procedures. Follow-up CT images showed no evidence of migration or recanalization of any of the devices. Minimal artifact was noted from the AVP on CT. CONCLUSION: In this preliminary series, use of the AVP allowed for precise proximal splenic artery embolization.

Reteplase provocative visceral arteriography.

GOALS: To present the results of a new protocol for provocative visceral arteriography. BACKGROUND: Acute lower gastrointestinal hemorrhage (LGIB) usually stops spontaneously. In the absence of an identifiable source, if bleeding is recurrent, provocative visceral arteriography has been advocated for diagnosis. Prior studies using Streptokinase, Urokinase, or tissue plasminogen activator have reported a 33% to 37.5% rate of identifying the site of hemorrhage. STUDY: We report a retrospective analysis of 9 patients in whom provocative visceral arteriography was performed using a new protocol with Reteplase as the fibrinolytic agent. All patients had recurrent, massive LGIB without definable source. Initial arteriography did not elicit a site of bleeding. Five units of Reteplase were administered over 1 minute into the inferior mesenteric artery, the superior mesenteric artery or both vessels sequentially. Arteriography was repeated after 5 to 10 minutes. RESULTS: Colonic hemorrhage was induced in 89% of patients. There were no procedure-related complications. CONCLUSIONS: Reteplase may prove safe and effective as a provocative agent, stimulating bleeding to allow localization, in patients with occult, recurrent, massive LGIB.